InvestorsHub Logo
Followers 56
Posts 8436
Boards Moderated 0
Alias Born 05/14/2015

Re: None

Friday, 12/17/2021 8:41:16 AM

Friday, December 17, 2021 8:41:16 AM

Post# of 118396
Looks like Oncopharma is going to lose its exclusivity with Regen's IP as they have not been able to raise the funds to start the clinical trials. That must mean we'll finally see Lilly step up in January and give Koos the billions he is deserved. We should all thank Skil and OTC for all of the hard work they have put into bringing awareness to the masses on how Koos is going to cure cancer and make us all wealthy beyond our wildest dreams.

FACTS are stubborn things